APP
MLNT

Avantax Planning Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Avantax Planning Partners’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6
Closed – – 1389
2018
Q3 		$0 Buy
+6
New – ﹤0.01% 1470
2018
Q2 		– Sell
-6
Closed – – 1734
2018
Q1 		$0 Buy
+6
New – ﹤0.01% 1890